Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | tyrosine protein kinase Src64B | 0.0138 | 0.2232 | 0.1945 |
Loa Loa (eye worm) | hypothetical protein | 0.0269 | 0.9508 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.0269 | 0.9508 | 1 |
Echinococcus multilocularis | tyrosine protein kinase Src64B | 0.0138 | 0.2232 | 0.1945 |
Loa Loa (eye worm) | TK protein kinase | 0.0123 | 0.1365 | 0.1435 |
Loa Loa (eye worm) | TK/ABL protein kinase | 0.0258 | 0.8886 | 0.9346 |
Echinococcus multilocularis | tyrosine protein kinase Fgr | 0.0138 | 0.2232 | 0.1945 |
Echinococcus granulosus | tyrosine protein kinase ABL1 | 0.0258 | 0.8886 | 0.9312 |
Echinococcus multilocularis | proto oncogene tyrosine protein kinase LCK | 0.0138 | 0.2232 | 0.1945 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0138 | 0.2232 | 0.1945 |
Echinococcus granulosus | tyrosine kinase | 0.0123 | 0.1365 | 0.0985 |
Echinococcus multilocularis | tyrosine protein kinase lyn lyn a protein tyrosine kinase lymphocyte specific protein tyrosine kinase | 0.0138 | 0.2232 | 0.1945 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0138 | 0.2232 | 0.1945 |
Echinococcus granulosus | tyrosine protein kinase Blk | 0.0123 | 0.1365 | 0.0985 |
Loa Loa (eye worm) | TK protein kinase | 0.0107 | 0.0475 | 0.05 |
Brugia malayi | Tyrosine-protein kinase abl-1 | 0.0144 | 0.2554 | 0.1461 |
Echinococcus multilocularis | tyrosine protein kinase lyn tyrosine protein kinase blk | 0.0138 | 0.2232 | 0.1945 |
Loa Loa (eye worm) | hypothetical protein | 0.0269 | 0.9508 | 1 |
Echinococcus granulosus | tyrosine protein kinase Src42A | 0.0138 | 0.2232 | 0.1945 |
Loa Loa (eye worm) | SRC-1 | 0.0138 | 0.2232 | 0.2348 |
Echinococcus multilocularis | tyrosine protein kinase Abl | 0.013 | 0.1757 | 0.1419 |
Echinococcus granulosus | 3'partial|tyrosine protein kinase Fgr | 0.0138 | 0.2232 | 0.1945 |
Echinococcus granulosus | proto oncogene tyrosine protein kinase LCK | 0.0138 | 0.2232 | 0.1945 |
Echinococcus granulosus | tyrosine protein kinase Lyn | 0.0138 | 0.2232 | 0.1945 |
Schistosoma mansoni | tyrosine kinase | 0.0242 | 0.7997 | 0.7421 |
Brugia malayi | Tyrosine-protein kinase abl-1 | 0.013 | 0.1757 | 0.0482 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0138 | 0.2232 | 0.1945 |
Loa Loa (eye worm) | TKL/MLK/LZK protein kinase | 0.0269 | 0.9508 | 1 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0138 | 0.2232 | 0.1945 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0138 | 0.2232 | 0.1945 |
Echinococcus granulosus | mitogen activated protein kinase kinase kinase | 0.0269 | 0.9508 | 1 |
Echinococcus granulosus | tyrosine kinase|tyrosine protein kinase Fyn | 0.0123 | 0.1365 | 0.0985 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0123 | 0.1365 | 0.0985 |
Echinococcus multilocularis | tyrosine protein kinase Srms | 0.0123 | 0.1365 | 0.0985 |
Echinococcus multilocularis | tyrosine protein kinase Src42A | 0.0138 | 0.2232 | 0.1945 |
Entamoeba histolytica | protein kinase, putative | 0.0107 | 0.0475 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase ABL1 | 0.0258 | 0.8886 | 0.9312 |
Echinococcus granulosus | tyrosine protein kinase Src42A | 0.0114 | 0.0873 | 0.044 |
Echinococcus multilocularis | tyrosine protein kinase Blk | 0.0123 | 0.1365 | 0.0985 |
Brugia malayi | SRC-1 | 0.0138 | 0.2232 | 0.1065 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0138 | 0.2232 | 0.1945 |
Brugia malayi | Protein kinase domain containing protein | 0.0269 | 0.9508 | 1 |
Echinococcus multilocularis | tyrosine protein kinase Src42A | 0.0114 | 0.0873 | 0.044 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 10 uM | Cytotoxicity against Homo sapiens (human) MCF7 cells after 48 hr by SRB assay | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.